Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter

Use tags to find relevant records

3D printed implants

Ablation methods

Allogeneic mesenchymal stem cells

Ambulatory ECG monitoring

Aortic abdominal aneurysm

Aortic root replacement

Arthroplasty

Arthroscopy

Assisted ventilation

Atherectomy

Austria

Autologous chondrocyte implantation

Automated external defibrillator

AV fistula

AV graft

Balloon kyphoplasty

Bariatric surgery

Baroreflex activation therapy

Barrett’s oesophagus

Belgium

Benign prostatic hyperplasia

Biopsy

Bone Conductive Hearing Device

Breast reconstruction

Bronchial thermoplasty

Burns

Caesarean section

Cancer

Capsule endoscopy

Carbon ion therapy

Cardiac ablation

Cardiac computer tomography

Cardiac pacemaker

Cardiac resynchronization therapy

Cardiac Resynchronization Therapy Defibrillator (CRT-D)

Cardiovascular devices

Cardiovascular procedures

Carotid endarterectomy

Cataract

Cell therapy

Cholecystectomy

Chronic obstructive pulmonary disease

Chronic wounds

Clinical guidelines

Cochlear implants

Commissioning

Companion diagnostic tests

Computed tomography

Conditional reimbursement

Connected medical devices

Continuous glucose monitoring (CGM)

Coronary interventions

Coronary percutaneous revascularization procedures

Coronary procedures

Coronavirus

Coverage with evidence development (CED)

Diagnostics

12

Mar 2018

The Andalusian Agency for Health Technology Assessment released an evaluation report on the utility of exome sequencing for diagnosed dysmorphic syndromes

In November 2017, the Andalusian Agency for Health Technology Assessment (AETSA) published an evaluation report (assessed within literature review) on the utility of exome sequencing for diagnosed dysmorphic syndromes.